Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
Subcutaneous anti-d globulin application is a safe treatment option of immune thrombocytopenia in children
Annals of Hematology, 10/23/09
Trebo MM et al. – Subcutaneous (sc) administration of anti–d seems to offer the same efficacy as intravenous administration but with less side effects. Here the authors report the experience with sc anti–d for pediatric immune thrombocytopenia (ITP). SC anti–d is not only an efficient means of treating ITP in children but is also a safe and convenient one.
Today in Peds Allergy/Immunology...keeping you current
Receive free subspecialty "5-minute updates" via email
Role of adenoids and adenoiditis in children with allergy and otitis media
Current Allergy and Asthma Reports, 10/22/09
Update on vaccination guidelines for allergic children
Expert Review of Vaccines, 10/29/09
Montelukast in the treatment of asthma and beyond
Expert Review of Clinical Immunology, 11/23/09
Sponsor
Article Search
Sponsor


See Latest Articles


